AMRA® MAsS Scan is offered as one of the medical device services of AMRA where AMRA® The protocol uses rapid magnetic resonance imaging (MRI) from the neck to the knee to produce a patient-specific report. The report contains the MAsS, anatomical and color-coded images, as well as precise body composition measurements with contextual information based on AMRA’s benchmark database.
Now, with the help of an objective, actionable and easy-to-understand MAsS, clinicians in Canada can accurately assess the muscles before and after organ transplantation to better understand the patient’s health. For example, clinicians can more accurately predict, diagnose, and monitor sarcopenia; or they can track a patient’s muscle health by detecting large and small changes in muscle and fatness.
Eric Converse, CEO of AMRA, said: “We are very excited to bring this technology to Canada. AMRA® The MAsS Scan will greatly benefit patients by enabling clinicians to assess sarcopenia, take action, and improve patient outcomes. The Muscle Assessment Score is simple to use and understand, and it establishes a common language among physicians for sarcopenia. an MRI already prescribed. “
Learn more about AMRA® Mass scan enabled AMRA website.
About AMRA Medical
AMRA is a digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, the ability to automatically produce multiple fat and muscle biomarkers with unmatched precision and accuracy, as well as contextual disease information, all at from a single rapid MRI of the whole body.
SOURCE AMRA Medical